Showing results (1371-1380 of 1,861) with videos related to
Sort By:
Pageof 187
The Oncologist|February 3, 2009
Dual inhibition of the epidermal growth factor receptor pathway with cetuximab and erlotinib: a phase I study in patients with advanced solid malignanciesMichael J Guarino, Charles J Schneider, Martha A Hosford, et al.Clinical Hemorheology and Microcirculation|June 4, 2019
Cellular inflammation in pulmonary hypertension: Detailed analysis of lung and right ventricular tissue, circulating immune cells and effects of a dual endothelin receptor antagonistIlonka Rohm, Katja Grün, Linda Marleen Müller, et al.Molecular Cancer Therapeutics|October 27, 2011
A polymeric nanoparticle encapsulated small-molecule inhibitor of Hedgehog signaling (NanoHHI) bypasses secondary mutational resistance to Smoothened antagonistsVenugopal Chenna, Chaoxin Hu, Dipankar Pramanik, et al.Journal of Neurointerventional Surgery|February 13, 2020
Single-center experience of using high definition (Hi-Def) imaging during neurointervention treatment of intracranial aneurysms using flow divertersSwetadri Vasan Setlur Nagesh, Kunal Vakharia, Muhammad Waqas, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 10, 2013
Impact of graft loss among kidney diseases with a high risk of post-transplant recurrence in the paediatric populationKarlijn J Van Stralen, Enrico Verrina, Mirco Belingheri, et al.Cardiovascular Research|January 23, 2021
A new player in the game: treatment with antagomiR-21a-5p significantly attenuates histological and echocardiographic effects of experimental autoimmune myocarditisMoritz Mirna, Vera Paar, Albert Topf, et al.Cancer Research|April 3, 2008
Therapeutic efficacy of ABT-737, a selective inhibitor of BCL-2, in small cell lung cancerChristine L Hann, Vincent C Daniel, Elizabeth A Sugar, et al.Cell Death & Disease|May 9, 2025
Dopamine D2 receptor agonists abrogate neuroendocrine tumour angiogenesis to inhibit chemotherapy-refractory small cell lung cancer progressionSk Kayum Alam, Anuradha Pandit, Li Wang, et al.HIV Medicine|July 5, 2011
Impaired antibody memory to varicella zoster virus in HIV-infected children: low antibody levels and avidity*A G L'Huillier, T Ferry, D S Courvoisier, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 14, 2014
A randomized, phase 2 trial of Docetaxel with or without PX-866, an irreversible oral phosphatidylinositol 3-kinase inhibitor, in patients with relapsed or metastatic non-small-cell lung cancerBenjamin Levy, Alexander Spira, Daniel Becker, et al.Pageof 187